CEVA, Inc.: Needham cuts target price to $30 from $43
CEVA•Needham cut its price target for CEVA to $30 from $43.
Related News
Ionis Pharmaceuticals: Needham cuts target price to $54 from $86
IONS•
Federal Circuit hears appeal over Acadia's Nuplazid formulation patent
ACAD•
AutoNation: Stephens cuts target price to $184 from $188
AN•
Emerging Asian equities rally after oil prices slide on peace deal hopes
SPY•
Vir Biotechnology target raised to $22 from $17 by Leerink Partners
VIR•